Circulating triglyceride levels have been found to be positively assoc
iated with plasminogen activator inhibitor-1 (PAI-1) activity in patie
nts with non-insulin dependent diabetes mellitus (NIDDM). The aim of t
his study was to examine the independent effect of raised triglyceride
levels on the regulators of fibrinolysis in healthy subjects, while m
aintaining circulating insulin levels comparable to those observed in
the fasting state in NIDDM, Eight healthy men were studied on separate
occasions. Intralipid(TM) 10% (lipid) or sodium chloride infusion 0.9
% (control) were administered intravenously at 45 ml/h for 180 min in
random order, On each occasion, insulin was infused at 0.0075 U/kg/h a
nd blood glucose levels clamped at fasting values. During the clamp, s
erum triglyceride levels were significantly higher in the lipid study
(1.79+/-0.39 [mean+/-SEM] vs 0.83+/-0.16 mmol/l; p<0.005), while serum
insulin levels were comparable (14.2+/-0.7 and 13.2+/-0.8 mU/l). Howe
ver, there were no significant differences between the lipid and contr
ol studies for PAI-1 activity, PAI-1 antigen, tissue-type plasminogen
activator (t-PA) activity and t-PA antigen levels during the clamp bef
ore and after 10 min venous occlusion, We conclude, therefore, that an
acute elevation in circulating triglyceride levels does not influence
the regulators of fibrinolysis in the presence of low circulating ins
ulin levels.